On behalf of the editorial board, I am pleased to announce that *Infection and Chemotherapy* is being published as an open-access English journal beginning in March, 2013 with volume 45, issue 1 to facilitate its international competitiveness. We believe that this change represents a significant step toward the globalization of the Korean Society of Infectious Disease and the Korean Society for Chemotherapy, providing you with the opportunity to communicate with a wide range of scientists around the world.

*Infection and Chemotherapy* is a journal born in 2003 that extensively integrates two journals: *Kamyeom*, published by the Korean Society of Infectious Diseases since 1969 \[[@B1]\], and *Hwahakyobeophwakhaeji*, published by the Korean Society for Chemotherapy since 1983 \[[@B2]\]. Over the past 44 years, more than 1,870 valuable original articles and case reports have been published in these historical journals. *Infection and Chemotherapy* is a member of the Korean Association of Medical Journal Editors \[[@B3]\] and KoreaMed \[[@B4]\], and we have endeavored to maintain the high quality of the journal.

We are obliged to accelerate the speed of taking, discussing, and distributing new and evidence-based international academic medical information in order to keep up with rapid updates of clinical and laboratory research in the field of infectious diseases. This is why *Infection and Chemotherapy* just converted to English, closing its character as a Korean journal even though it was published in a Korean and English mixed format, with the last edition, volume 44, issue 6, published in December 2012.

Articles published in *Infection and Chemotherapy* can be obtained for free from an English website ([www.icjourmal.org](http://www.icjourmal.org)), where their abstracts and full-text PDF files can be located. Furthermore, all articles can also be viewed on the website of KoreaMed ([www.koreamed.org](http://www.koreamed.org)) and found on the KoreaMed Synapse (<http://synapse.koreamed.org>) search system.

*Infection and Chemotherapy* will continue striving to accomplish its goal of serving as one of the major international journals focusing on infectious diseases. It will include valuable editorials, several review articles by renowned scholars, novel original articles, practice guidelines, and informative case reports.

*Infection and Chemotherapy* welcomes articles on a wide range of clinical descriptions of clinical infectious diseases as well as public health issues, microbiology, parasitology and infection immunity, evaluations of current and novel treatments, and the promotion of optimal practices for diagnoses and treatments.

Finally, I would like to express my sincere appreciation for the ongoing effort of the many editors in chief who have worked to keep *Infection and Chemotherapy* worthy of its name as a professional journal.
